| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 807.87B | 816.88B | 801.70B | 766.93B | 693.25B | 586.90B |
| Gross Profit | 112.80B | 113.74B | 113.06B | 89.42B | 80.84B | 73.80B |
| EBITDA | 80.15B | 45.78B | 81.48B | 63.32B | 57.38B | 49.66B |
| Net Income | 42.09B | 27.86B | 48.17B | 39.19B | 21.54B | 32.00B |
Balance Sheet | ||||||
| Total Assets | 701.61B | 728.71B | 708.50B | 700.21B | 618.42B | 598.50B |
| Cash, Cash Equivalents and Short-Term Investments | 117.14B | 108.40B | 97.23B | 103.22B | 72.95B | 92.13B |
| Total Debt | 97.50B | 64.27B | 72.29B | 51.09B | 51.77B | 50.87B |
| Total Liabilities | 288.69B | 282.76B | 285.32B | 279.63B | 252.56B | 259.65B |
| Stockholders Equity | 397.65B | 430.54B | 407.68B | 405.02B | 349.22B | 322.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 37.60B | 13.55B | 33.39B | -12.89B | 11.13B |
| Operating Cash Flow | 0.00 | 77.45B | 55.71B | 66.71B | 13.66B | 34.51B |
| Investing Cash Flow | 0.00 | -41.61B | -47.78B | -10.35B | -41.76B | 4.99B |
| Financing Cash Flow | 0.00 | -26.95B | -23.63B | -21.00B | -11.55B | -27.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥692.20B | 45.41 | ― | 2.60% | 1.89% | -39.75% | |
70 Outperform | ¥95.38B | 24.87 | ― | 1.61% | 0.65% | 569.87% | |
66 Neutral | ¥643.19B | -13.88 | 3.35% | 3.18% | 2.15% | -6.81% | |
64 Neutral | ¥200.80B | 6.35 | 13.11% | 2.87% | 9.86% | 119.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥403.46B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% | |
55 Neutral | ¥403.84B | 135.95 | ― | 1.93% | <0.01% | -83.75% |